Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biotricity Q3 2024 Adj EPS $(0.12) Beats $(0.44) Estimate, Sales $2.97M Miss $3.00M Estimate

Author: Benzinga Newsdesk | February 20, 2024 07:14pm
Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by 71.82 percent. The company reported quarterly sales of $2.97 million which missed the analyst consensus estimate of $3.00 million by 0.90 percent. This is a 20.90 percent increase over sales of $2.46 million the same period last year.

Posted In: BTCY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist